LEVERKUSEN, GERMANY – Bayer confirms advanced negotiations with Monsanto concerning a proposed transaction. While key terms and conditions have not yet been agreed, Bayer would be prepared to provide a transaction consideration of $127.50 per Monsanto share only in connection with a negotiated transaction. There can be no assurance that the parties will enter into an agreement.
The proposed transaction would be subject to regulatory approval and other customary closing conditions. The key conditions of a definitive transaction agreement must be approved by the Supervisory Board of Bayer AG.
For more information, visit www.advancingtogether.com.
The proposed transaction would be subject to regulatory approval and other customary closing conditions. The key conditions of a definitive transaction agreement must be approved by the Supervisory Board of Bayer AG.
For more information, visit www.advancingtogether.com.
Latest from Garden Center
- University of Florida study unlocks secrets of invasive short-spined thrips
- Kian-backed Eden Brothers adds Michael Hollenstein as CEO, expands senior leadership team
- IPPS announces organizational rebrand, new website and 2026 international membership drive
- Growscape appoints chief manufacturing officer, Brian Cunningham
- Experts help Florida cemetery become state’s first to earn arboretum accreditation
- Fresh Inset appoints Gordon Robertson as general manager, North America
- Society of American Florists planning fifth annual Next Gen LIVE! conference for young floral professionals
- Applications now open for American Floral Endowment graduate scholarships
